« Back

Myla Lai-Goldman, M.D.

Myla P. Lai-Goldman, M.D.

Chief Executive Officer and President, GeneCentric Therapeutics, Inc.

Age 60
Director since 2014

Dr. Lai-Goldman has been Chief Executive Officer and President of GeneCentric Therapeutics, Inc.—a molecular diagnostics company—since June 2011 and serves as director for the company. She is also managing partner of Personalized Science, LLC, a clinical diagnostics consulting company that she founded in 2008. Previously, Dr. Lai-Goldman was Chief Executive Officer and Chief Scientific Officer of CancerGuide Diagnostics, Inc. Before joining CancerGuide Diagnostics, she held various roles—including Executive Vice President, Chief Medical Officer and Chief Scientific Officer—at Laboratory Corporation of America Holdings and its predecessor company, Roche Biomedical Laboratories. Additionally, Dr. Lai- Goldman has been a venture partner at Hatteras Venture Partners since August 2011.